OtherBASIC SCIENCE INVESTIGATIONS
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
Jérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, Marcel Ricard, Martine Labbé, Claudia Ceccarelli, Claire Schvartz, Michel Henri-Amar, Stéphane Bardet and Florent de Vathaire
Journal of Nuclear Medicine May 2008, 49 (5) 845-852; DOI: https://doi.org/10.2967/jnumed.107.046599
Jérôme-Philippe Garsi
Martin Schlumberger
Carole Rubino
Marcel Ricard
Martine Labbé
Claudia Ceccarelli
Claire Schvartz
Michel Henri-Amar
Stéphane Bardet
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue 5
May 2008
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
Jérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, Marcel Ricard, Martine Labbé, Claudia Ceccarelli, Claire Schvartz, Michel Henri-Amar, Stéphane Bardet, Florent de Vathaire
Journal of Nuclear Medicine May 2008, 49 (5) 845-852; DOI: 10.2967/jnumed.107.046599
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
Jérôme-Philippe Garsi, Martin Schlumberger, Carole Rubino, Marcel Ricard, Martine Labbé, Claudia Ceccarelli, Claire Schvartz, Michel Henri-Amar, Stéphane Bardet, Florent de Vathaire
Journal of Nuclear Medicine May 2008, 49 (5) 845-852; DOI: 10.2967/jnumed.107.046599
Jump to section
Related Articles
Cited By...
- Pregnancy outcomes in papillary thyroid cancer survivors:A retrospective cohort study
- The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
- Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
- Pregnancy Outcome After 131I Therapy
- Reply: Pregnancy Outcome After 131I Therapy
- Risks Associated with Therapeutic 131I Radiation Exposure